MACC1-AS1 overexpression significantly enhances the level of HK2 and GLUT1 [107], suggesting that MACC1-AS1 promotes glycolysis and leads to metabolic reprogramming in glioma progression. The gene discussed is MACC1; the disease is central nervous system cancer.